Cost-effectiveness analysis of tropisetron vs. chlorpromazine-dexamethasone in the control of acute emesis induced by highly emetogenic chemotherapy in children

Cost-effectiveness analysis of tropisetron vs. chlorpromazine-dexamethasone in the control of acute emesis induced by highly emetogenic chemotherapy in children

To perform a cost-effectiveness analysis (CEA) between a standard antiemetic regimen-chlorpromazine + dexamethasone (CPM-DEX)- and a 5-HT3 receptor antagonist-tropisetron (TROP)--in the control of acute emesis induced by highly emetogenic chemotherapy in children, considering tw...

Full description

Bibliographic Details
Main Authors: Tejedor, I. (I.), Jimenez, M. (Miguel), Sierrasesumaga, L. (Luis), Giraldez, J. (J.)
Format: info:eu-repo/semantics/article
Language:eng
Published: Springer 2012
Subjects:
Antiemetics/adverse effects/economics/therapeutic use
Dexamethasone/adverse effects/economics/therapeutic use
Vomiting/chemically induced/prevention & control
Online Access:https://hdl.handle.net/10171/23753

Internet

https://hdl.handle.net/10171/23753

Similar Items